Friday 6 November 2026
Export VCYT’s income statement to Excel — free account
Veracyte, Inc.
VCYT Healthcare Diagnostics & Research
Veracyte, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $517.1 million, up 16.0% from fiscal 2024.
- Revenue
- +15.1%
- EPS
- +62.5%
- Free cash flow
- −9.63%
Quarter to September 2026, against a year earlier
24.19
0.19
+0.79%
Follow VCYT
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 9.43% | 8.77% | 6.93% | 5.34% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 8 | 8 | 8 | |
| 8.63% | 8.09% | 6.40% | 4.90% | ||
ROIC |
4.33% | 7.32% | 5.35% | 4.03% | |
Return on Tangible Assets |
31.05% | 21.44% | 18.01% | 14.72% | |
Average Days of Receivables |
35.63 | 35.19 | 33.76 | 31.52 | |
Free Cash Flow per Share |
2.01 | 2.08 | 1.95 | 1.61 | |
Free Cash Flow |
161.95 | 165.99 | 155.34 | 126.63 | |
Capital Expenditures |
(11.93) | (12.39) | (10.82) | (9.68) | |
| Other line items | |||||
Cash ROIC |
11.30% | 8.86% | 8.71% | 7.35% | |
Accounts Receivable Turnover |
11.12 | 10.70 | 10.43 | 11.34 | |
Accounts Payable Turnover |
21.42 | 16.33 | 13.93 | 23.38 | |
Inventory Turnover |
0.00 | 6.67 | 6.90 | 7.31 | |
Average Days of Payables |
21.74 | 18.43 | 16.00 | 10.84 | |
Days of Inventory on Hand |
0.00 | 52.03 | 49.61 | 48.50 | |
Tax Rate |
0.07 | (0.01) | (0.03) | (0.03) | |
Research and Development Expense of Revenue |
18.83% | 16.62% | 14.80% | 13.69% | |
Selling, General and Administrative Expense of Revenue |
35.72% | 35.88% | 37.57% | 40.79% | |
Share Based Compensation of Revenue |
8.89% | 8.63% | 8.38% | 8.43% | |
Operating CF/Net income |
1.37 | 1.56 | 1.89 | 2.05 | |
Depreciation/Fixed assets |
0.00 | 0.83 | 0.82 | 0.82 | |
Capex/Depreciation |
0.00 | (0.68) | (0.59) | (0.53) | |
Revenue per Share |
7.23 | 7.03 | 6.81 | 6.58 | |
Operating CF per Share |
2.16 | 2.23 | 2.09 | 1.73 | |
Capex per Share |
(0.15) | (0.15) | (0.14) | (0.12) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026